Dental Pulp Stem Cells Ameliorate Elastase-Induced Pulmonary Emphysema by Regulating Inflammation and Oxidative Stress

References

• Raherison C, Girodet PO. Epidemiology of COPD. Eur Respir Rev. 2009;18(114):213–221. doi:10.1183/09059180.00003609
   PubMedGoogle Scholar
• Rabe KF, Hurd S, Anzueto A, Barnes PJ, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555. doi:10.1164/rccm.200703-456SO
   PubMed Web of Science ®Google Scholar
• Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;10082:389.
   Google Scholar
• Kaur M, Chandel J, Malik J, Naura AS. Particulate matter in COPD pathogenesis: an overview. Inflamm Res. 2022;71(7–8):797–815. doi:10.1007/s00011-022-01594-y
   PubMedGoogle Scholar
• Fischer BM, Pavlisko E, Voynow JA. Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation. Int J Chron Obstruct Pulmon Dis. 2011;6:413–421. doi:10.2147/COPD.S10770
   PubMed Web of Science ®Google Scholar
• Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J. 2006;28(1):219–242. doi:10.1183/09031936.06.00053805
   PubMed Web of Science ®Google Scholar
• Drost EM, Skwarski KM, Sauleda J, et al. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax. 2005;60(4):293–300. doi:10.1136/thx.2004.027946
   PubMed Web of Science ®Google Scholar
• Wang C, Zhou J, Wang J, et al. Progress in the mechanism and targeted drug therapy for COPD. Signal Transduct Target Ther. 2020;5(1):248. doi:10.1038/s41392-020-00345-x
   PubMed Web of Science ®Google Scholar
• McLeod CM, Mauck RL. On the origin and impact of mesenchymal stem cell heterogeneity: new insights and emerging tools for single cell analysis. Eur Cell Mater. 2017;34:217–231. doi:10.22203/eCM.v034a14
   PubMed Web of Science ®Google Scholar
• Chen X, Wang F, Huang Z, et al. Clinical applications of mesenchymal stromal cell-based therapies for pulmonary diseases: an update and concise review. Int J Med Sci. 2021;18(13):2849–2870. doi:10.7150/ijms.59218
   PubMedGoogle Scholar
• Costela-Ruiz VJ, Melguizo-Rodriguez L, Bellotti C, et al. Different sources of mesenchymal stem cells for tissue regeneration: a guide to identifying the most favorable one in orthopedics and dentistry applications. Int J Mol Sci. 2022;23(11):6356. doi:10.3390/ijms23116356
   PubMedGoogle Scholar
• Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U S A. 2000;97(25):13625–13630. doi:10.1073/pnas.240309797
   PubMed Web of Science ®Google Scholar
• Potdar PD, Jethmalani YD. Human dental pulp stem cells: applications in future regenerative medicine. World J Stem Cells. 2015;7(5):839–851. doi:10.4252/wjsc.v7.i5.839
   PubMed Web of Science ®Google Scholar
• Zhang SY, Ren JY, Yang B. Priming strategies for controlling stem cell fate: applications and challenges in dental tissue regeneration. World J Stem Cells. 2021;13(11):1625–1646. doi:10.4252/wjsc.v13.i11.1625
   PubMedGoogle Scholar
• Sui B, Wu D, Xiang L, et al. Dental pulp stem cells: from discovery to clinical application. J Endod. 2020;46(9):S46–S55. doi:10.1016/j.joen.2020.06.027
   PubMedGoogle Scholar
• Ren H, Sang Y, Zhang F, et al. Comparative analysis of human mesenchymal stem cells from umbilical cord, dental pulp, and menstrual blood as sources for cell therapy. Stem Cells Int. 2016;2016:3516574. doi:10.1155/2016/3516574
   PubMed Web of Science ®Google Scholar
• Verma K, Bains R, Bains VK, et al. Therapeutic potential of dental pulp stem cells in regenerative medicine: an overview. Dent Res J. 2014;11(3):302–308.
   PubMedGoogle Scholar
• Makino E, Nakamura N, Miyabe M, et al. Conditioned media from dental pulp stem cells improved diabetic polyneuropathy through anti-inflammatory, neuroprotective and angiogenic actions: cell-free regenerative medicine for diabetic polyneuropathy. J Diabetes Investig. 2019;10(5):1199–1208. doi:10.1111/jdi.13045
   PubMedGoogle Scholar
• Li S, Luo L, He Y, et al. Dental pulp stem cell-derived exosomes alleviate cerebral ischaemia-reperfusion injury through suppressing inflammatory response. Cell Prolif. 2021;54(8):e13093. doi:10.1111/cpr.13093
   PubMedGoogle Scholar
• Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest. 2013;144(1):266–273. doi:10.1378/chest.12-2664
   PubMed Web of Science ®Google Scholar
• Park SW, Lee AY, Lim JO, et al. Loranthus tanakae Franch. & Sav. suppresses inflammatory response in cigarette smoke condensate exposed bronchial epithelial cells and mice. Antioxidants. 2022;11(10). doi:10.3390/antiox11101885
   Google Scholar
• Bousnaki M, Bakopoulou A, Pich A, Papachristou E, Kritis A, Koidis P. Mapping the secretome of dental pulp stem cells under variable microenvironmental conditions. Stem Cell Rev Rep. 2022;18(4):1372–1407.
   PubMedGoogle Scholar
• Bronckaers A, Hilkens P, Fanton Y, et al. Angiogenic properties of human dental pulp stem cells. PLoS One. 2013;8(8):e71104. doi:10.1371/journal.pone.0071104
   PubMed Web of Science ®Google Scholar
• Katsha AM, Ohkouchi S, Xin H, et al. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther. 2011;19(1):196. doi:10.1038/mt.2010.192
   PubMed Web of Science ®Google Scholar
• Thurlbeck WM. Measurement of pulmonary emphysema. Am Rev Respir Dis. 1967;95(5):752–764. doi:10.1164/arrd.1967.95.5.752
   PubMedGoogle Scholar
• Chen M, Huang Z, Bi H, et al. Effects of bone marrow‑derived mesenchymal stem cell transplantation on chronic obstructive pulmonary disease/obstructive sleep apnea overlap syndrome in rats. Mol Med Rep. 2019;20(5):4665–4673. doi:10.3892/mmr.2019.10714
   PubMedGoogle Scholar
• Qian Y, Yan L, Wei M, Song P, Wang L. Seeds of Ginkgo biloba L. inhibit oxidative stress and inflammation induced by cigarette smoke in COPD rats through the Nrf2 pathway. J Ethnopharmacol. 2023;301:115758. doi:10.1016/j.jep.2022.115758
   PubMedGoogle Scholar
• Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2008;295(1):L1–L15. doi:10.1152/ajplung.90200.2008
   PubMed Web of Science ®Google Scholar
• von Bahr L, Batsis I, Moll G, et al. Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation. Stem Cells. 2012;30(7):1575–1578. doi:10.1002/stem.1118
   PubMed Web of Science ®Google Scholar
• Antunes MA, Abreu SC, Cruz FF, et al. Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema. Respir Res. 2014;15(1):118. doi:10.1186/s12931-014-0118-x
   PubMed Web of Science ®Google Scholar
• Mehraban S, Gu G, Ma S, Liu X, Turino G, Cantor J. The proinflammatory activity of structurally altered elastic fibers. J Respir Cell Mol Biol. 2020;63(5):699–706. doi:10.1165/rcmb.2020-0064OC
   PubMed Web of Science ®Google Scholar
• Devos FC, Maaske A, Robichaud A, et al. Forced expiration measurements in mouse models of obstructive and restrictive lung diseases. Respir Res. 2017;18(1):123.
   PubMedGoogle Scholar
• Gu W, Song L, Li XM, et al. Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways. Sci Rep. 2015;5:8733. doi:10.1038/srep08733
   PubMed Web of Science ®Google Scholar
• Fukui E, Funaki S, Kimura K, et al. Adipose tissue-derived stem cells have the ability to differentiate into alveolar epithelial cells and ameliorate lung injury caused by elastase-induced emphysema in mice. Stem Cells Int. 2019;2019:5179172. doi:10.1155/2019/5179172
   PubMed Web of Science ®Google Scholar
• Antus B, Harnasi G, Drozdovszky O, Barta I. Monitoring oxidative stress during chronic obstructive pulmonary disease exacerbations using malondialdehyde. Respirology. 2014;19(1):74–79. doi:10.1111/resp.12155
   PubMed Web of Science ®Google Scholar
• Mates JM. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology. 2000;153(1–3):83–104. doi:10.1016/S0300-483X(00)00306-1
   PubMed Web of Science ®Google Scholar
• Boutten A, Goven D, Artaud-Macari E, Boczkowski J, Bonay M. NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease. Trends Mol Med. 2011;17(7):363–371. doi:10.1016/j.molmed.2011.02.006
   PubMed Web of Science ®Google Scholar